Ac immune ceo andrea pfeifer receives first sef.womenaward for ceo of the year

Lausanne, switzerland, sept. 03, 2021 (globe newswire) -- ac immune sa (nasdaq: aciu), a swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced its co-founder and ceo andrea pfeifer has been awarded by the swiss economic forum (sef) with the sef.womenaward, in the category ceo of the year, during a ceremony at the sef meeting in interlaken on september 2, 2021.
ACIU Ratings Summary
ACIU Quant Ranking